HWA
EW icon

HHM Wealth Advisors’s Edwards Lifesciences EW Stock Holding History

HHM Wealth Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.3K Hold
202
– – ﹤0.01% 546
2026
Q1 		$16.2K Buy
+202
New +$16.7K ﹤0.01% 543
2025
Q1 		– Sell
-21
Closed -$1.55K – 964
2024
Q4 		$1.55K Buy
+21
New +$1.47K ﹤0.01% 782
2024
Q3 		– Sell
-600
Closed -$55.4K – 798
2024
Q2 		$55.4K Buy
+600
New +$53.1K 0.01% 324

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
AAIS
ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

HHM Wealth Advisors's EW Position: Q2 2026 in Review

HHM Wealth Advisors held its Edwards Lifesciences (EW) position steady in Q2 2026 at 202 shares worth $18.3K. The position accounts for ﹤0.01% of the portfolio, ranked #546.

HHM Wealth Advisors first reported a position in EW in Q2 2024 and has held it in 4 quarters since. The position peaked at $55.4K in Q2 2024. 414 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • HHM Wealth Advisors held 202 shares of Edwards Lifesciences worth $18.3K as of Q2 2026.
  • HHM Wealth Advisors left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up ﹤0.01% of HHM Wealth Advisors's portfolio in Q2 2026, its #546 holding.
  • HHM Wealth Advisors first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 4 quarters since.
  • HHM Wealth Advisors's Edwards Lifesciences position peaked at $55.4K in Q2 2024.
  • 414 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on HHM Wealth Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.